SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q1 Trading Update

18 Apr 2019 07:00

RNS Number : 5559W
Rentokil Initial PLC
18 April 2019
Β 

Β 

RENTOKIL INITIAL PLC (RTO)

FIRST QUARTER TRADING UPDATE

18 April 2019

Β 

(Β£m)

Β 

Q1 2019

Growth

Β 

Β 

AER

AER

CER

Ongoing Revenue1

Β 

603.6

10.6%

8.9%

Revenue

Β 

607.4

10.3%

8.6%

Β 

Overview

Trading has started well across our businesses in Q1 with Ongoing Revenue1 increasing by 8.9%, of which 4.0% was Organic Revenue2 growth (Q1 2018: 3.2%, FY 2018: 3.7%) and 4.9% was from acquisitions.

Ongoing Revenue in Pest Control grew by 12.0%, 5.0% Organic (Q1 2018: 4.7%), with good performances being delivered across both Growth and Emerging markets, which rose by 12.1% and 11.5% respectively. Hygiene has made a very positive start to the year, with Ongoing Revenue growth of 7.2% and Organic Revenue growth of 4.3% (Q1 2018: 1.8%). Ongoing Revenue in our Protect & Enhance markets was in line with Q1 2018.

M&A

​We signed eight acquisitions in Q1, four in Pest Control (primarily in North America and Latin America) and four in Hygiene, with combined annualised revenues of c. Β£29m in the year prior to purchase. We are encouraged about our prospects for further M&A this year and our pipeline of value-enhancing opportunities is strong. Our guidance for M&A spend in 2019 remains in the range of Β£200m to Β£250m. Β 

Pension Scheme and Funding

In December 2018 the Company reached agreement for a bulk annuity insurance 'buy-in' for its UK Defined Benefit Pension scheme ("the Scheme") in contemplation of a full 'buy-out' which is expected to complete in early 2020. Good progress towards buy-out is being made andΒ we now anticipate a pre-tax cash surplus of c. Β£40m will be returned to the Company on completion.

Ahead of the refinancing of our €500m bond maturing in September this year, we are intending to hold a non-deal, bond investor education roadshow in London, France, Germany, the Netherlands, Nordics and Asia. We will release further details in due course.

​Commenting on today's announcement Andy Ransom, Chief Executive, said:

"We have had a good start to 2019 and I'm pleased with our performance in the first three months of this year. I am confident of another year of successful growth for the Company, in line with market expectations."

Β 

Enquiries:

Β 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Β 

Β 

Β 

Β 

Media:

Malcolm Padley

Rentokil Initial plc

07788 978199

Β 

Β 

Β 

Β 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

Β 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

Β 

AER - actual exchange rates; CER - constant 2018 exchange rates

Β 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTZMGMDRNMGLZM
Date   Source Headline
17th Aug 201211:49 amRNSAmendment-Interim Results to 30.06.12
6th Aug 20125:20 pmRNSAcquisition
3rd Aug 20127:00 amRNSInterim Results for six months to 30.06.12
31st Jul 20123:52 pmRNSHolding(s) in Company
28th Jun 20129:23 amRNSDirector/PDMR Shareholding
9th May 20126:09 pmRNSAMENDING RNS released 16:51 - 09.05.12
9th May 20124:51 pmRNSDirector/PDMR Shareholding
8th May 20127:00 amRNSDirector/PDMR Shareholding
4th May 20127:00 amRNSInterim Management Statement - Q1
2nd May 20121:24 pmRNSResult of AGM
10th Apr 201210:39 amRNSPublication of Prospectus
29th Mar 20129:20 amRNSAnnual Financial Report
19th Mar 20123:58 pmRNSDirector/PDMR Shareholding
2nd Mar 201211:37 amRNSDividend - Record date amendment
2nd Mar 20127:00 amRNSFinal Results
24th Feb 20127:00 amRNSDirectorate Change
7th Feb 201211:48 amRNSHolding(s) in Company
3rd Feb 20124:37 pmRNSHolding(s) in Company
13th Jan 20129:41 amRNSHolding(s) in Company
6th Jan 20125:21 pmRNSHolding(s) in Company
21st Dec 20114:37 pmRNSHolding(s) in Company
5th Dec 20115:01 pmRNSAcquisition of MSS Facilities Management
30th Nov 20114:31 pmRNSHolding(s) in Company
28th Nov 20115:05 pmRNSHolding(s) in Company
21st Nov 20117:00 amRNSProposed acquisition of building services division
18th Nov 201112:49 pmRNSHolding(s) in Company
14th Nov 20119:32 amRNSHolding(s) in Company
11th Nov 20114:29 pmRNSHolding(s) in Company
7th Nov 20117:00 amRNSTrading update for 3rd quarter ended 30.09.11
17th Oct 20112:58 pmRNSHolding(s) in Company
12th Oct 20113:25 pmRNSHolding(s) in Company
5th Oct 20111:59 pmRNSHolding(s) in Company
5th Oct 201111:59 amRNSHolding(s) in Company
23rd Sep 20119:49 amRNSHolding(s) in Company
11th Aug 20118:30 amRNSDirector/PDMR Shareholding
10th Aug 20114:14 pmRNSHolding(s) in Company
3rd Aug 20111:58 pmRNSDirector/PDMR Shareholding
2nd Aug 20114:32 pmRNSHolding(s) in Company
29th Jul 20117:00 amRNSInterim results for six months to 30 June 2011
20th Jul 20117:00 amRNSMulti Country Contract with Rentokil
19th Jul 20114:11 pmRNSHolding(s) in Company
14th Jul 201112:54 pmRNSMerger Update
14th Jun 201111:00 amRNSMD and FD of City Link Appointed
13th Jun 20114:00 pmRNSMerger Update
12th May 20111:00 pmRNSResult of AGM
9th May 20111:29 pmRNSDirector/PDMR Shareholding
6th May 20117:00 amRNS1st Quarter Results
6th Apr 20114:00 pmRNSMerger Update
6th Apr 20117:00 amRNSCorporate Responsibility Report 2010
1st Apr 20115:30 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.